Skip to main content
. Author manuscript; available in PMC: 2011 Oct 12.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006690. doi: 10.1002/14651858.CD006690.pub2
Methods Parallel randomised controlled trial

Participants SETTING: Outpatients at the Foshan TCM Hospital, Guangdong Province, China
WHO PARTCIPATED: n=72 (36 in the intervention group, M/F 19/13, mean age
46.3yrs; 36 in the control group, M/F 20/13, mean age 47.1yrs)
INCLUSION CRITERIA: IGT (WHO 1999)
EXCLUSION CRITERIA: none reported
CO-MORBIDITIES: none reported
CO-MEDICATIONS none reported

Interventions INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Xiaoke Yuye (Huang
qi, huang jing, he shou wu, zhi mu) 10ml three times per day, plus lifestyle modification
(diet and exercise)
CONTROL: lifestyle modification (diet and exercise)

Outcomes Fasting blood glucose (mmol/L), 2hr-GTT (mmol/L), HbA1c (%), total cholesterol
(mmol/L), BMI, normalisation of fasting blood glucose (n), incidence of diabetes (n)
All outcomes were measured at baseline and at trial completion (24 months)
No adverse effects in the treatment group.

Study details DURATION OF INTERVENTION: 2 years
DURATION OF FOLLOW-UP: 2 years
RUN-IN PERIOD: none

Publication details LANGUAGE OF PUBLICATION: Chinese
COMMERCIAL FUNDING: no
NON-COMMERCIAL FUNDING: no
PUBLICATION STATUS (PEER REVIEW JOURNAL): yes
PUBLICATION STATUS (JOURNAL SUPPLEMENT): no
PUBLICATION STATUS (ABSTRACT): yes

Stated aim of study Quote “To observe the effects of Xiaoke yuye on patients with impaired glucose
tolerance.”

Notes

Risk of bias table